Medtronic: Ready to Deal Again
Executive Summary
A decade ago, Medtronic shook up itself and the device industry with a series of large deals over a short period of time. In the process, the company tranformed itself from a leader in cardiac rhythm management into the industry's largest, most diversified device company. More recently, the company has been quieter, focusing on smaller deals, both acquisitions and minority investments. In But in this interview, Medtronic's head of Corporate Development, Bob White, says that Medtronic is ready to deal again and talks about the kinds of companies it's interested in.
You may also be interested in...
CareFusion Makes Its First Steps Count
Just six months removed from Cardinal Health, CareFusion is making headlines with new products, anti-trust lawsuits and signficant acquisitions. The three individual events reflect the aggressive attitude CareFusion executives intend to carry now that they’re free from Cardinal Health.
Medtech Investing 2009: What's Changed?
The medical device industry is undergoing a crisis of funding, but not of confidence, according to a panel of investors convened at Windhover's recent medtech conference, In3 West,. The conference panel sought to explore how the medical device investment community is operating in these troubled times, how they will invest going forward, and how they will support their companies if things don't improve. We were especially curious to know if the funding challenges that start-ups face are really due to the overall dire economy, or if that dark cloud merely masks changing fundamentals in the medical device industry that are making it more difficult for companies to find funding, gain FDA approval, and enjoy a healthy exit. Our panel weighs in on the matter.
What Do Device Investors Want?
Perhaps the question most often posed by entrepreneurs and start-up company executives is, "What are device investors looking for these days?" At Windhover's recent IN3 West conference, industry leaders provided several different perspectives on that question. In this article, we excerpt portions of a discussion that featured two prominent organizations with long-term commitments to medical device investing, but which operate from different points on the investor spectrum: Medtronic Inc. and the Carlyle Group.